Marissa C Van Maaren (M C van Maaren, M C Van Maaren, Marissa C van Maaren)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Acute Heart Failure

Peritoneal Dialysis

Ejection Fraction

Prognostic Factors

Top Venues

International journal of cancer

Breast cancer research and treatment

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lori M van Roozendaal, Marissa L G Vane, E Colier, Luc J A Strobbe, M de Boer, Gabe S Sonke, Marissa C Van Maaren, Marjolein L Smidt
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed. Breast cancer research and treatment (2023)
Willemien J Kruik-Kollöffel, Job van der Palen, Carine J M Doggen, Marissa C Van Maaren, H Joost Kruik, Edith M Heintjes, Kris L L Movig, Gerard C M Linssen
Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. PloS one 15 (12) (2020)
Daniël J van der Meer, Iris Kramer, Marissa C Van Maaren, Paul J van Diest, Sabine C Linn, John H Maduro, Luc J A Strobbe, Sabine Siesling, Marjanka K Schmidt, Adri C Voogd
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017. International journal of cancer 148 (9) (2020)
Marissa C Van Maaren, Robert F Kneepkens, Joke Verbaan, Peter C Huijgens, Valery E P P Lemmens, Rob H A Verhoeven, Sabine Siesling
A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients. PloS one 14 (1) (2019)
Cornelia D van Steenbeek, Marissa C Van Maaren, Sabine Siesling, Annemieke Witteveen, Xander A A M Verbeek, Hendrik Koffijberg
Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands. BMC medical research methodology 19 (1) (2019)
Marissa C Van Maaren, Saskia le Cessie, Luc J A Strobbe, Catharina G M Groothuis-Oudshoorn, Philip M P Poortmans, Sabine Siesling
Different statistical techniques dealing with confounding in observational research: measuring the effect of breast-conserving therapy and mastectomy on survival. Journal of cancer research and clinical oncology 145 (6) (2019)
Liza A Hoveling, Marissa C Van Maaren, Tom Hueting, Luc J A Strobbe, Mathijs P Hendriks, Gabe S Sonke, Sabine Siesling
Validation of the online prediction model CancerMath in the Dutch breast cancer population. Breast cancer research and treatment 178 (3) (2019)
Erik Heeg, Perla J Marang-van de Mheen, Marissa C Van Maaren, Kay Schreuder, Rob A E M Tollenaar, Sabine Siesling, Monique E M M Bos, Marie-Jeanne T F D Vrancken Peeters
Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer. International journal of cancer 147 (1) (2019)
Marissa C Van Maaren, L J A Strobbe, L B Koppert, P M P Poortmans, S Siesling
Nationwide population-based study of trends and regional variation in breast-conserving treatment for breast cancer. The British journal of surgery 105 (13) (2018)
Marissa C Van Maaren, Linda de Munck, Luc J A Strobbe, Gabe S Sonke, Pieter J Westenend, Marjolein L Smidt, Philip M P Poortmans, Sabine Siesling
Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study. International journal of cancer 144 (2) (2018)
Mirelle Lagendijk, Marissa C Van Maaren, Sepideh Saadatmand, Luc J A Strobbe, Philip M P Poortmans, Linetta B Koppert, Madeleine M A Tilanus-Linthorst, Sabine Siesling
Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients. International journal of cancer 142 (1) (2017)